Germany Sees Stable COVID-19 Rates Amid New Variants; Low Risk Assessed

As of August 2026, COVID-19 incidence rates in Germany remain stable with the highest 7-day incidence recorded in Schleswig-Holstein at 0.3 per 100,000, while several federal states report zero cases. The Robert Koch Institute identifies three main circulating variants: NB.1.8.1 ('Nimbus'), recombinant XFG ('Stratus'), and BA.3.2 ('Cicada'), with Nimbus being the most frequently detected. According to the World Health Organization, these variants pose a low risk, and current vaccines continue to protect effectively against severe disease.

Symptoms linked to the XFG variant include fever, cough, fatigue, sore throat, body aches, and diarrhea, whereas Nimbus and Cicada infections often cause severe throat pain. Despite these variants, there have been ongoing declines in hospitalizations and deaths.

Antigen tests developed in previous years remain valid if they are not expired and have been stored properly, reassuring the public about testing reliability. The Ständige Impfkommission (Stiko) has revised its vaccination guidelines, recommending booster shots primarily for risk groups aged 75 and older, reflecting the reduced threat level and improved immunity across the healthy adult population.

While mask mandates have been lifted in public spaces and transport, masks are still advised for immunocompromised individuals, and people exhibiting respiratory symptoms are encouraged to reduce social contacts and practice hygiene.

This measured approach aligns with the current low risk status and the ongoing emphasis on protecting vulnerable groups while maintaining preparedness in the face of emerging variants.